Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...

Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

In November, Mr. Biden set out to change that with a new rule that would drastically expand access to this type of medication ...

Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that they really could protect against dementia ...

SAO PAULO, April 7 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab, the producer of Ozempic, Wegovy and other medications ... of Ozempic as soon as the drug's patent expires in Brazil.

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

Diabetes and weight loss treatments such as Ozempic and Wegovy, known as GLP-1 agonists ... Receive a weekly dose of discovery in your inbox! We'll also keep you up to date with New Scientist ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

Ozempic looked like a miracle drug. But it didn’t work for me - Doctors say it’s not uncommon for patients to not lose weight ...